# OnCo record paper-aall0434-nelarabine-t-all-dunsmore-jco-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aall0434-nelarabine-t-all-dunsmore-jco-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aall0434-nelarabine-t-all-dunsmore-jco-2020" ;
  schema:name "AALL0434: nelarabine in newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults"@en ;
  schema:description "Adding the T-cell-specific drug nelarabine to intensive chemotherapy improved disease-free survival in childhood T-cell acute lymphoblastic leukaemia and cut central nervous system relapses, in the largest T-ALL trial ever run."@en ;
  schema:url <https://onco.cc/key-papers/paper-aall0434-nelarabine-t-all-dunsmore-jco-2020/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.20.00256>, <https://pubmed.ncbi.nlm.nih.gov/32813610/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.20.00256> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Dunsmore KP, Winter SS, Devidas M, et al." ;
  onco:cancers <https://onco.cc/cancers/all-paediatric-high-risk/> ;
  onco:drugs <https://onco.cc/drugs/nelarabine/> ;
  onco:trials <https://onco.cc/trials/aall0434/> ;
  onco:journals <https://onco.cc/journals/jco/> .